I'd say it was more left over liability rather than anything major upfront costs. They haven't even selected the service provider for the flow test.
Its actually not normal company behaviour to raise a few days before xmas and most would wait till the new year to do so. So its telling me more they had a hole that needed to be filled fast.
- Forums
- ASX - By Stock
- IVZ
- Ann: Quarterly Report and Cashflow
Ann: Quarterly Report and Cashflow, page-36
-
- There are more pages in this discussion • 76 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IVZ (ASX) to my watchlist
|
|||||
Last
7.0¢ |
Change
0.002(2.94%) |
Mkt cap ! $99.25M |
Open | High | Low | Value | Volume |
6.9¢ | 7.0¢ | 6.7¢ | $101.9K | 1.487M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 6.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 354854 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.069 |
5 | 240973 | 0.068 |
5 | 887635 | 0.067 |
7 | 248441 | 0.066 |
6 | 286432 | 0.065 |
Price($) | Vol. | No. |
---|---|---|
0.070 | 354854 | 3 |
0.071 | 5417 | 1 |
0.073 | 325000 | 2 |
0.074 | 200000 | 2 |
0.075 | 737400 | 5 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
IVZ (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online